The COVID-19 pandemic has caused a significant slow-down in mergers and acquisitions (M&A). As this situation’s seriousness has become apparent, many M&A transactions have been called off. Others have been put on hold, as parties seek to better understand the pandemic’s impacts on acquirers, target companies and the economy as a whole.

But what about transactions that were signed prior to this pause in deal making? Will buyers still be required to close these deals? The answer is transaction-specific. However, in attempting to answer this question, parties to M&A acquisition agreements are likely to look first to whether COVID-19 constitutes a “material adverse effect.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]